92 related articles for article (PubMed ID: 20032008)
21. Oestrogen receptors and small nuclear ring finger protein 4 (RNF4) in malignant ovarian germ cell tumours.
Salonen J; Butzow R; Palvimo JJ; Heikinheimo M; Heikinheimo O
Mol Cell Endocrinol; 2009 Aug; 307(1-2):205-10. PubMed ID: 19524139
[TBL] [Abstract][Full Text] [Related]
22. Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer.
Kontos S; Papatsoris A; Kominea A; Melachrinou M; Tanoglidi A; Kachrilas S; Karavitakis M; Balampani E; Sotiropoulou-Bonikou G
Urol Int; 2011; 87(2):151-8. PubMed ID: 21525722
[TBL] [Abstract][Full Text] [Related]
23. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
25. Invasion in follicular thyroid cancer cell lines is mediated by EphA2 and pAkt.
O'Malley Y; Lal G; Howe JR; Weigel RJ; Komorowski RA; Shilyansky J; Sugg SL
Surgery; 2012 Dec; 152(6):1218-24. PubMed ID: 23158188
[TBL] [Abstract][Full Text] [Related]
26. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
27. uPA receptor expression in benign and malignant thyroid tumors.
Kim SJ; Shiba E; Taguchi T; Tsukamoto F; Miyoshi Y; Tanji Y; Takai S; Noguchi S
Anticancer Res; 2002; 22(1A):387-93. PubMed ID: 12017319
[TBL] [Abstract][Full Text] [Related]
28. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract][Full Text] [Related]
29. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
30. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
31. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
Yang GS; Wang Y; Wang P; Chen ZD
Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481
[TBL] [Abstract][Full Text] [Related]
32. Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex.
Kelly SN; McKenna TJ; Young LS
J Endocrinol; 2005 Jul; 186(1):33-42. PubMed ID: 16002533
[TBL] [Abstract][Full Text] [Related]
33. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression.
Cavallini A; Notarnicola M; Giannini R; Montemurro S; Lorusso D; Visconti A; Minervini F; Caruso MG
Eur J Cancer; 2005 Jul; 41(10):1487-94. PubMed ID: 15949936
[TBL] [Abstract][Full Text] [Related]
35. Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.
Bergqvist J; Elmberger G; Ohd J; Linderholm B; Bjohle J; Hellborg H; Nordgren H; Borg AL; Skoog L; Bergh J
Eur J Cancer; 2006 May; 42(8):1104-12. PubMed ID: 16603346
[TBL] [Abstract][Full Text] [Related]
36. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
37. Expression of Met protein in thyroid tumours.
Ruco LP; Ranalli T; Marzullo A; Bianco P; Prat M; Comoglio PM; Baroni CD
J Pathol; 1996 Nov; 180(3):266-70. PubMed ID: 8958803
[TBL] [Abstract][Full Text] [Related]
38. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY
Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382
[TBL] [Abstract][Full Text] [Related]
39. Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas.
Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
Anticancer Res; 2003; 23(3B):2349-53. PubMed ID: 12894514
[TBL] [Abstract][Full Text] [Related]
40. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer.
Myers E; Fleming FJ; Crotty TB; Kelly G; McDermott EW; O'higgins NJ; Hill AD; Young LS
Br J Cancer; 2004 Nov; 91(9):1687-93. PubMed ID: 15477868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
